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In situ implantation of a valved femoral vein allograft in a neonate with
pulmonary atresia with intact ventricular septum and severe
tricuspid regurgitation
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MD,a Noboru Motomura, MD,a Shinichi Takamoto, MD,a Hiroko Sugimura, MD,b Kazuhiko Shibuya, MD,b Hitoshi Kato,
MD,b and Shigeo Yamaki, MD,c Tokyo and Shiroishi, Japan
We report a case of pulmonary atresia with intactventricular septum and severe tricuspid regurgita-tion in a neonate who was treated by in situimplantation of a valved femoral vein allograft in
the anatomic position to eliminate pulmonary regurgitation and to
augment forward flow into the highly resistant and hypoplastic
pulmonary circulation.
Clinical Summary
At 38 weeks’ gestation, a 2334-g boy was delivered by cesarean
section. Oxygen saturation of arterial blood (SaO2) was 80% with
room air, and the cardiothoracic ratio was 0.92. Echocardiography
demonstrated a dysplastic tricuspid valve, which showed nodular
and echodense valvular tips and a tethered septal leaflet, no for-
ward flow across the pulmonary valve without regurgitant signals,
and patent ductus arteriosus. Alprostadil administration was
started. The Great Ormond Street Ebstein echocardiogram score1
was 0.58, grade 2. On postnatal day 1, the unwell neonate required
endotracheal intubation. On postnatal day 3, an emergency right
hemicolectomy was done to treat meconium peritonitis. Instability
of the systemic circulation and progression of the cardiomegaly
indicated surgical intervention for the congenital heart defects on
postnatal day 14.
A mildly hypothermic cardiopulmonary bypass was instituted.
After patent ductus arteriosus ligation, the heart was arrested by
infusion of blood cardioplegic solution. The main pulmonary ar-
tery (PA) was transected at just above the sinotubular junction, and
the atretic membrane was removed. As a result, a dilator of 9 mm
was permitted to pass into the right ventricular (RV) outflow. A
femoral vein allograft containing a bicuspid competent valve with
an external diameter of 8 mm (supplied by the University of Tokyo
Tissue Bank, Tokyo, Japan) was thawed. A segment of the allo-
graft with the valve was interposed between the proximal and
distal PA stumps (Figure 1), and the pump was terminated. The
myocardial ischemic time was 22 minutes. SaO2 was 67% with
100% inspired oxygen and 10 ppm nitric oxide gas inhalation.
Central venous pressure was 16 mm Hg. Systemic arterial blood
pressure was 53/28 mm Hg with 10  dobutamine and dopamine
and 0.2  epinephrine. A peritoneal dialysis catheter was inserted.
Forward flow through the allograft was confirmed by transesoph-
ageal echocardiography. Regurgitant signals through the valve
were trivial. During the night of the same day, SaO2 dropped
despite 20 ppm inhaled nitric oxide. Echocardiography demon-
strated dynamic RV outflow tract obstruction. The patient under-
went right modified Blalock-Taussig shunt (BTS) with a 3.5-mm
polytetrafluoroethylene graft the next day.
Back distribution of peritoneal dialysis fluid forced us to intro-
duce continuous venovenous hemofiltration. On the second post-
operative day, cardiothoracic ratio, SaO2, and central venous pres-
sure were improved (75%, 82%, and 8 mm Hg, respectively) with
the same respirator conditions and without nitric oxide inhalation.
Thereafter, however, the patient developed sepsis and dissemi-
nated intravascular coagulopathy, resulting in hemodynamic dete-
rioration. The patient died on the 15th postoperative day. Postmor-
tem examination demonstrated widely patent RV outflow with
modified BTS. Histologic examination of the lung revealed severe
pulmonary vascular disease, which showed thickening of the in-
tima but not the media (Figure 2).
Discussion
The outlook for the neonate with tricuspid regurgitation with
severe cardiomegaly is generally poor. Yamaki and colleagues2
examined lungs from neonates with severe tricuspid regurgitation,
revealing that the lung hypoplasia and mean medial thickness of
the small pulmonary arteries were more similar to those in a
control group than to those in neonates with a diaphragmatic
hernia. Although the procedure reported by Starnes and cowork-
ers3 has palliated the condition of these patients, if at all possible
salvaging the RV should be a goal in view of the long-term
functional advantage. Recently we reported the feasibility of a
saphenous vein valved allograft as RV-PA conduit in the modified
Norwood operation.4 This experience encouraged us to use a
valved femoral vein allograft. In this case, dynamic RV outflow
tract obstruction interfered with effective forward flow, and even-
tually BTS was required. Nevertheless, in situ implantation com-
bined with or without BTS is recommended for a selected sub-
group of patients with this anomaly, rather than use of an
extracardiac RV-PA conduit, because RV outflow reconstruction
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in a physiologic route will yield laminar flow through the allograft,
thus allowing superior longevity.5
From the histologic report on the lung, severe pulmonary
hypertension was suggested in this case. This informed us of the
wide range variation of the structural changes of the pulmonary
vasculature and also made us aware that the optimal treatment for
this anomaly should be discussed on a case-by-case basis.
We thank Ms Sakiko Shibusawa and Dr Hiroo Takayama for
their help in shipping and thawing the allograft.
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Figure 2. Two pulmonary arterioles 70 m in diameter show
cellular and fibrous thickening of intima. Medial thickening was
not notable.
Figure 1. Segment of femoral vein allograft containing competent
valve was anastomosed to proximal PA stump.
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